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Coenzyme Q10: Regulators of 
Mitochondria and beyond
Gopi Marappan
Abstract
The role of coenzyme Q10 (CoQ10) was relatively unknown except its 
involvement in the oxidative phosphorylation at electron transport chain. Recent 
researches revealed its association in conditions like maintenance of cardiac and 
pulmonary functions, regulation of cell proliferation to cancer prevention, etc. 
CoQ10, a potent lipophilic antioxidant, prevents the cellular biomolecules viz., 
DNA, RNA, lipid bilayers, etc. Endogenous de novo synthesis will be sufficient to 
maintain the daily body needs; however, synthesis showed age-dependent reduc-
tion. Commercial preparations are available for oral consumption; there are even 
food-grade preparations for cattle, swine and poultry. A major concern with oral 
intake of CoQ10 was bioavailability due to its lipophilic nature. CoQ10 has been 
recommended for patients under continuous statin therapy as these drugs inhibit 
the pathway of CoQ10 biosynthesis. The use of CoQ10 in various cardiac and tumor 
conditions indicates that its activity is not only due to its antioxidant activity but 
also due to its apoptosis property. Apart from human uses, CoQ10 is now used in 
food animals especially broilers as they were fed with high energy dense diet there 
will be leakage of electrons at electron transport chain level which adversely affects 
the bird’s performance and also used in treatment of ascites mortality.
Keywords: coenzyme Q10, antioxidant, mitochondrial regulators, reduced, 
cholesterol synthesis, cancer
1. Introduction
Coenzymes are the cofactors in the body, which are essential for numerous enzy-
matic reactions at various levels. One such enzyme is coenzyme Q10 (CoQ10) and 
also widely known as ubiquinone. As the name ubiquinone suggests, this coenzyme 
is ubiquitous in nature. However, the identification of coenzyme Q10 (CoQ10) was 
accidental when Crane and co-authors in 1957 [1] were involved in the investigation 
of the mitochondrial electron transport system, they first identified and isolated 
this enzyme from the beef heart. The fundamental role of CoQ10 is in the mito-
chondrial respiratory chain and in oxidative phosphorylation [2], for which he was 
awarded the Nobel Prize in Chemistry in 1978 [3]. The CoQ10 is an endogenously 
synthesized lipophilic compound present in all living cells (ubiquitous in nature); 
hence, it is also designated as ubiquinones [4]. Coenzyme Q10 (CoQ10) is a lipid-
soluble compound involved in mitochondrial adenosine triphosphate (ATP) synthe-
sis (bioenergetics) and reduces the pulmonary hypertension syndrome and ascites 
mortality [5]. CoQ10 does various roles along with its three important functions 
in the body, namely as an electron carrier in respiratory chain, antioxidant [6] and 
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cell signaling and gene expression [7]. These functions have practical applications 
in clinical practice and its use as food/feed supplementation [8]. Supplementing 
coenzyme Q10 is known to provide health benefits, much like nutraceuticals even 
in healthy individuals [9] and individuals with metabolic disorders like oxidative 
phosphorylation disorder [10]. CoQ10 also maintains membrane fluidity [11] and 
protects membranous phospholipid against peroxidation [12] and in plant photo-
synthesis [13]. Normal respiratory rate requires the maintenance of a high CoQ10 
concentration, and even a small decrease is deleterious [14].
2. Coenzyme Q10
2.1 Is coenzyme Q10 a vitamin?
CoQ10 is similar to vitamin K in its chemical structure, but it is not considered 
a vitamin because it is synthesized in the body [15, 16]. All the fat-soluble vitamins 
(A, D, E and K) possess isoprene units in their structures. Likewise, coenzyme Q 
also has an isoprenoid (seen as A, D, E and K), a quinone structure (as in vitamin 
K) and cyclized chromanol (vitamin E). A definition to which a molecule is consid-
ered as a vitamin is as follows: an organic compound with small molecular weight, 
not to be synthesized in the body and supplemented through the diet; the absence 
of this will lead to a deficiency syndrome; converted to an active coenzyme form 
required for metabolic activity. Day-to-day findings make CoQ10 nearly fit into 
the typical definition for a vitamin. Being endogenously synthesized by all animal 
tissues might rule them out for a vitamin status. But vitamin D3 and vitamin C are 
endogenously synthesized from cholesterol and glucose, respectively, and are still 
given the vitamin status; hence, CoQ10 might be termed as vitamin Q as expressed 
by folkers. Supplementing coenzyme Q10 provides health benefits to the likes of 
nutraceuticals [9].
2.2 Chemistry of coenzyme Q10
CoQ10 is a 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone [16]. It 
contains 10 isoprene units and is the predominant form in both mammals and 
birds, whereas CoQ9 (9 isoprene units) is predominant in rodents [14]. Due to its 
lipophilic nature and higher molecular weight (863 Da), the oral bioavailability of 
CoQ10 is low [8]. Following absorption, it is taken up by the liver for incorporation 
into very low density lipoprotein (VLDL) particles before being released into cir-
culation [15] [6]. An increase (about 160%) in CoQ10 levels in the VLDL and LDL 
fractions following its dietary intake. To counteract the problem of low bioavail-
ability, currently different types of carriers like lipid emulsion of solid triglyceride, 
tocopherol succinate and phospholipids (Ultrasome®) [17], different cyclodextrins 
[18] and gel form (UbiQGel®) [19], are being tried with great success.
2.3 Biosynthesis of ubiquinone
CoQ10 is endogenously synthesized in all human and animal cells [20]. Two 
pathways are involved in CoQ10 biosynthesis in the body. The biosynthesis of 
polyprenyl side chain occurs through the mevalonate pathway. This reaction starts 
with acetyl-coenzyme A and ends up with farnesyl pyrophosphate (FPP). This FPP 
also acts as a substrate for the biosynthesis of isoprenylated proteins, dolichol and 
cholesterol. However, the quinone head is synthesized from either the amino acid 
tyrosine or the phenylalanine [21].
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Major findings of coenzyme Q10 [22] are as follows:
• Coenzyme Q is distributed throughout all cell components.
• Unlike vitamins K and E, exogenous CoQ is absorbed into liver and not in other 
tissues.
• All the tissues in the body have the capacity to independently synthesis CoQ , 
but this capacity is less during developing early embryonic tissues.
• The mevalonate pathway is used by animals, plants and fungi for the synthesis 
of CoQ but not used by some bacteria and also for synthesis of vitamin K in 
mycobacteria.
• In liver, accumulation of CoQ occurs due to lower catabolism or enhanced 
synthesis under conditions like deficiency of vitamin A, cold stress exposure 
and excess thyroid secretion.
• Excesses of CoQ in liver either by endogenous synthesis or by absorption has 
a negative feedback mechanism to inhibit its own synthesis, which also leads 
to low serum cholesterol content as de novo synthesis of cholesterol shares the 
same biosynthetic pathway.
Presently, coenzyme Q10 is produced by chemical synthesis, semi-chemical 
synthesis or microbial conversion and is commonly available. Humans or animals 
fed with non-vegetarian diet will have higher CoQ10 intake and its absorption 
varies with the amount and uptake increases with increase in fat content. The 
absorption of reduced form is more than that of the oxidized CoQ10, and with its 
large molecular weight, about 60% of intake is excreted through the feces [23]. The 
yeast fermentation technique, which involves with inclusion of B vitamins in their 
culture, is the major form of industrial CoQ10 synthesis. Recently, CoQ10 is avail-
able as feed grade in powder form for swine and poultry but in gel form for human 
preparations [24, 25].
3. Therapeutic indications
3.1 Cancer therapy
CoQ10 a lipophilic antioxidant exhibits different biological activities like 
immune boosting, free radical scavenging and DNA protection. Studies on admin-
istration of CoQ10 have revealed promising results in prevention and/or treating 
cancers. Positive effect with breast cancer in patients consuming CoQ10 has been 
reported in recent publications [26–29].
3.2 Insufficiency of CoQ10 levels are considered as one of the risk factors
A significant lower level of CoQ10 is observed in cancerous tissues when 
compared to the normal tissues. CoQ10 is known for its counteraction of ROS 
in cellular and DNA integrity [30]. A case-control study [31, 32] revealed an 
inverse association between CoQ10 levels and incidence of breast cancer. An in 
vitro study with MCF-7 breast cancer cell lines where the cells were co-incubated 
with CoQ10 showed results with significant decrease in intracellular peroxide 
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formation and matrix metalloproteinase 2 activity and the effects were in a dose-
dependent manner [33].
Results further showed that CoQ10 had no inhibitory effect on apoptotic, 
anti-growth and anti-colonization effects of doxorubicin at any doses [34]. An 
animal study with mammary carcinoma model revealed that administration 
of CoQ10 at 40 mg/kg body weight restored the normal antioxidant level [35]. 
Reports suggest that increasing the dose of CoQ10 to 390 mg from 300 mg for more 
periods revealed resolution of tumor residue without any metastases [36–38] and 
increased the survivability [39]. Daily intake of a combination of 100 mg CoQ10, 
10 mg riboflavin and 50 mg niacin reduced the circulating tumor markers [40–46]. 
Consuming a combination of CoQ10 along with lipotropic factor L-carnitine 
reduced the tumor-related fatigue in subjects [47–50].
3.3 Coenzyme Q10 on ascites heart index (AHI) and ascites mortality
In fast-growing broilers, the impact of ascites mortality is very high (after 
5 weeks of age) as the farmers are not only losing the birds but also are incurring the 
feeding and rearing cost by the time. Feed restriction or skip-a-day feeding is fol-
lowed in broiler during finisher phase to avoid the problem of ascites, which results 
in poor body weight and feed efficiency. Few researchers are suggesting that ascites 
might be due to the bird’s inability to endogenously synthesize the CoQ10 demand. 
To counteract this, CoQ10 was used, and in fact, the importance of CoQ10 was felt 
with a reduction in ascites mortality in broilers when fed with CoQ10 [51]. Then, 
the term ascites heart index (AHI) comes into prominence, which gives more infor-
mation about the susceptibility of the birds to ascites. Ascites heart index (AHI), a 
sensitive index of pulmonary hypertension, is based on the relative ratio of the right 
ventricle to the total ventricle [52]. The AHI was further made into a more useful 
tool where broilers with AHI value of less than 0.27 without any fluid accumulation 
in abdomen are normal and those birds having AHI value more than 0.30 with fluid 
accumulation are pulmonary hypertensioned and prone to ascites mortality [53]. 
The relative heart weight of birds receiving CoQ10 at 20 mg kgG1 of diet was higher 
[54–58]. A reduction in AHI ratio in broilers fed with CoQ10 at 40 mg/kg of feed 
was noticed [59]. However, there was a lower heart weight with respect to percent-
age of body weight when broilers fed with 20 and 40 mg of CoQ10 [60]. Ascites 
mortality in broilers was reduced around 75% by CoQ10 supplementation at both 20 
and 40 mg/kg of diet. But at 40 mg/kg of diet supplementation, the incidence of leg 
problem was high. This reduction in ascites mortality (around 40%) was observed 
when broilers were fed CoQ9. These studies imply that CoQ , either 9 or 10 isoprene 
units, is able to reduce the broiler’s mortality due to ascites.
3.4 Coenzyme Q10 on lipid metabolism
Clinical human and animal studies suggested that dietary CoQ10 supple-
mentation improved the cholesterol metabolism in mammals. Nearly 10% lower 
cholesterol concentration was found in heart tissue of broilers when supplemented 
with CoQ10 [8]. CoQ10 supplementation decreased plasma total cholesterol 
concentration in humans [61] and rats [62]. CoQ10 was reportedly able to sup-
press the hepatic cholesterogenesis in rats [63] and in hens [64]. In an experiment 
in layer, chicks revealed reduced hepatic total cholesterol, plasma cholesterol and 
very low density lipoprotein (VLDL) cholesterol concentration by supplementa-
tion of CoQ10 at 400 and 800 mg/kg feed [65]. However, the plasma HDL, LDL 
cholesterol and total bile acids were not influenced by CoQ10 supplementation. 
The reduction in cholesterol level was due to decreased enzymatic activity of 
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3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) in the liver, but it had 
no influence on the enzymatic activity of 3-hydroxy-3-methylglutaryl coenzyme A 
synthetase (HMGS). Dietary CoQ10 supplementation suppressed hepatic cho-
lesterogenesis in laying hens [64] and observed a decrease in egg yolk cholesterol 
concentration by 7–10% on CoQ10 supplementation.
In a long-term CoQ10 feeding trial, reduced cholesterol synthesis with sup-
pression in cholesterol catabolism was observed resulting in return of hepatic 
cholesterol to normal level [65]. However, long-term (0–42 days) supplementa-
tion of CoQ10 at 20 and 40 mg kgG1 reduced the levels of serum total cholesterol 
and serum LDL cholesterol [58, 66]. The reduction in serum LDL cholesterol 
due to CoQ10 supplementation was attributed to the action of reduced form of 
CoQ10(H2), which induces characteristic gene expression patterns, which are 
translated into reduced LDL cholesterol level in human subjects. However, there 
were no reports of increase in the HDL cholesterol levels [58, 65]. CoQ10 reduced 
cholesterol metabolism in the plasma of patients with myocardial infarction [67] 
and in diabetic rats [62]. CoQ9, a major coenzyme Q in rats, decreases plasma total 
cholesterol concentration and suppresses hepatic cholesterogenesis [68].
3.5 Coenzyme Q10 antioxidant properties
Under the present intensive system of poultry production especially in trop-
ics, stresses due to environment, metabolic, managemental, etc. are inevitable, 
resulting in lower productivity, less nutrient retention, decreased serum and tissue 
vitamin level, humoral immunity (HI) and molecular changes like protein, nucleic 
acid denaturation and lipid peroxidation. Increased reactive oxygen species (ROS) 
metabolites compromise cell membrane integrity [53], which results in drip loss in 
muscles [60] affect keeping quality of muscles. Different nutrients and additives 
(like the use of synthetic amino acids, low heat increment nutrients, vitamins C, E 
and minerals such as selenium, zinc and magnesium or additive such as genistein 
and melatonin, and essential oils) are tried with varied success to counteract these 
stresses [69]. Aside from its role in mitochondrial bioenergetics, ubiquinone also 
affects membrane fluidity [11] and protects membrane phospholipids against 
peroxidation [12]. CoQ10 in its reduced form possesses free radical scavenging and 
increases total antioxidant capacity [70, 71]. CoQ10 is preferred over α-tocopherol 
[72] as CoQ10 enhances the activity of other enzymatic and non-enzymatic anti-
oxidants. The serum vitamin E level was increased by CoQ10 at 20 mg/kg [7, 58]. 
CoQ10 shows the property of regenerating the oxidized (inactive) α-tocopherol to 
reduce (an active form of vitamin E) [73]. Serum or liver malondialdehyde (MDA) 
is a product of lipid peroxidation and serves as a biomarker for oxidative damage in 
lipids. This suggested the protective action on lipid peroxidation in liver mitochon-
dria by CoQ10.
Superoxide dismutase (SOD) activity was increased in accordance with CoQ10 
supplementation in broilers and in rats [74]. An increase in hepatic SOD and 
anti-ROS capacity in broilers was observed by CoQ10 supplementation [55]. The 
supplementation of CoQ10 increases the SOD activity by antagonizing nitric 
oxide (NO) inactivation, thereby making more NO availability for the biological 
function that leads to extracellular SOD gene expression. The reduced glutathione 
and glutathione peroxidase activity was also increased by CoQ10 at 20 mg/kg. 
This synergistic action of CoQ10 is possible as it acts as a primary regenerating 
antioxidant [75]. However, supplementation at 40 mg kgG1 of diet resulted in 
no effect on serum vitamin E and SOD levels. This ineffectiveness of CoQ10 at 
40 mg kgG1 of diet is due to the auto-oxidation of CoQ10 resulting in higher pro-
duction of mitochondrial reactive oxygen species (ROS), which leads to oxidative 
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stress in the body. The development of auto-oxidation was observed in birds fed 
higher level of CoQ10 for prolonged duration.
4. Absorption and distribution
4.1 Coenzyme Q10 absorption among body tissues
The content of CoQ10 in different body tissues is well studied in human subjects, 
but there are not enough studies in farm animals or birds. The highest concentra-
tion of CoQ10 was found in the most active organs like heart, kidney and liver. The 
CoQ10 concentration depends on a balance between inputs and outputs. Inputs are 
the level of CoQ10, which is endogenously synthesized, plus dietary supply and the 
outputs are the usage by oxidative stress and cellular metabolism. An adult human 
body has approximately 2 g of CoQ10, where a daily replacement of 0.5 g should 
be done by both endogenous synthesis and dietary means. Therefore, an average 
body CoQ10 content turnover rate was around 4 days and dietary supply becomes 
essential with impairment in endogenous synthesis. The body content of CoQ10 
decreased rapidly after the age of 40 years in humans with reduced biosynthesis. 
CoQ10 supplementation reversed the reduced circulating CoQ10 concentrations in 
statin-treated subjects as statin inhibits the pathways involved in both cholesterol 
and CoQ10 supplementation. Various authors recommended daily intake of CoQ10 
of about 30–100 mg for healthy people over 40 years and 60–1200 mg for those 
undergoing an adjunctive therapy for some medical conditions.
4.2 Distribution in body tissues
The CoQ10 level in human tissues varies with inappropriate nutrition, smoking 
and different medical conditions such as cardiomyopathy, diabetes and neurological 
disorder conditions [76]. Similarly in broiler chicken, the concentration of CoQ10 
among different body tissues was recorded (Table 1) [77].
Among the organelles, larger amount of CoQ10 is found in mitochondria of 
heart cells (92.3–282.0 mg/kg), followed by liver (22.7–132.2 mg/kg) of cattle, 
swine and chicken. Being lipophilic, vegetable oils especially rape seed and peanut 
oils have a high content (63.5–77.0 mg/kg) of CoQ. This again proved that CoQ10 is 
required more by tissues that are very active.
CoQ10 to cholesterol index (QCI) is increasingly used as a measure for assess-
ment of meat quality. QCI was used as a reliable indicator of oxidative status, and 
the possible oxidative stresses induced by different food ingredients and consider 
them as oxidant foods [8]. In simple terms, muscles with higher oxidative stress 
Tissues Concentration (mg/kg)
Heart 92.3–192
Liver 116.2–132.2
Thigh 24.2–25
Breast 7.8–17.1
Wing 11.0
Whole chicken 14–21
Table 1. 
Concentration of CoQ10 in various body tissues [77].
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due to either metabolic activity or food would have a reduction of QCI value. The 
QCI value was higher in 20 mg/kg supplemented group suggestive of low oxidative 
stress. Auto-oxidation of CoQ10 at 40 mg of CoQ10/kg increased muscle meta-
bolic activity leading to reduced QCI value [78]. Due to its antioxidant property, 
CoQ10 supplementation will be helpful in reducing drip loss during meat storage. 
Supplementation with CoQ10 at 40 mg kgG1 diet improved breast muscle yield 
and reduced the drip loss in broilers [60]. The reduction in muscle drip loss was 
attributed to the reduced reactive oxygen metabolites, thereby improving the cell 
membrane integrity and improved water retention.
5. Conclusion
The role of coenzyme Q10 is widely being studied under various health condi-
tions including cancer and cardiac hypertrophy. Its importance in normal healthy 
life is quite evident and physicians are prescribing it for oral intake for persons who 
continuously smoke as well as for those under statin drug therapy. Recently, CoQ10 
was widely used in food animals especially broilers, which are highly susceptible to 
mortality due to ascites/sudden death syndrome as a result of its rapid growth rate.
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